Welcome to POINT’s newsletter!
We are thrilled to release the first of many newsletters of our project POINT, a space where you will find updates and news about the project, invitations to events, resources and material to be download, and much more.
POINT is a project funded by the European Union that aims to understand and address the long-term health risks for people who have had COVID-19. Even after recovering from the initial illness, many individuals face an increased risk of developing serious conditions such as heart, lung, or kidney problems months or even years later.
Through advanced biomarkers and a virtual twin model, POINT seeks to predict future health complications, develop standardized guidelines for healthcare professionals, and bridge the gap between scientific discoveries and their practical application in clinical settings. The project’s ultimate goal is to gain a comprehensive understanding of the post-acute phase of COVID-19 and to equip healthcare providers with the tools and guidelines necessary to effectively manage patients.
POINT is approaching its first anniversary, and we’ve had a productive year! Since our kickoff in January 2024, we have been laying the foundation for our research, bringing together experts from across Europe, and starting to collect crucial health data from patients. Early in 2024, clinical partners secured the ethical approvals required to conduct cohort and register-based studies. These cohorts, along with existing sample collections, provide the foundation needed to better understand the post-acute phase of COVID-19.
Read the whole newsletter here and stay updated about POINT by subscribing.
